A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis

被引：0
作者：
Wolfgang A. Schmidt
Bhaskar Dasgupta
Raashid Luqmani
Sebastian H. Unizony
Daniel Blockmans
Zhihong Lai
Regina H. Kurrasch
Ivana Lazic
Kurt Brown
Ravi Rao
机构：
[1] Immanuel Krankenhaus Berlin (Buch),Medical Center for Rheumatology
[2] Rheumatology,Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science
[3] Southend University Hospital NHS Foundation Trust,Department of General Internal Medicine
[4] University of Oxford,undefined
[5] Rheumatology,undefined
[6] Massachusetts General Hospital,undefined
[7] University Hospital Gasthuisberg,undefined
[8] Immunoinflammation,undefined
[9] GlaxoSmithKline,undefined
[10] Biostatistics,undefined
[11] GlaxoSmithKline,undefined
[12] Immunology and Specialty Medicine,undefined
[13] GlaxoSmithKline,undefined
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Clinical trial; Corticosteroid taper; Giant cell arteritis; Interleukin-6; Sirukumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：793 / 810
页数：17
相关论文
共 119 条
[1]  
Salvarani C(2004)Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period Arthritis Rheum 51 264-268
[2]  
Crowson CS(2017)Trial of tocilizumab in giant-cell arteritis N Engl J Med 377 317-328
[3]  
O'Fallon WM(2010)BSR and BHPR guidelines for the management of giant cell arteritis Rheumatology 49 1594-1597
[4]  
Hunder GG(2017)What is the impact of giant cell arteritis on patients’ lives? A UK qualitative study BMJ Open 7 e017073-270
[5]  
Gabriel SE(2011)Giant cell arteritis: suspect it, treat it promptly Cleve Clin J Med 78 265-40
[6]  
Stone JH(2016)Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study Rheumatology 55 33-30
[7]  
Tuckwell K(2020)2018 Update of the EULAR recommendations for the management of large vessel vasculitis Ann Rheum Dis. 79 19-176
[8]  
Dimonaco S(2001)Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis Clin Exp Rheumatol 19 171-201
[9]  
Dasgupta B(2014)Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients Medicine 93 194-356
[10]  
Borg FA(2016)Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study Rheumatology 55 347-849
12345678910